Prenatal Diagnosis · 2014 · 68 citations · 12 references
Life SciencesCell BiologyGeneticsMaternal-fetal MedicinePrenatal DiagnosisReproductive MedicineAneuploidyNoninvasive Prenatal TestingPregnancy DiagnosisPrenatal CytogeneticsPrenatal Genetic DiagnosisAneuploidy ScreeningFetal Aneuploidy DetectionNon-invasive Prenatal TestingPrenatal Chromosomal DiagnosisPrenatal Cytogenetic DiagnosisPrenatal Diagnosis Of AneuploidyPrenatal Sex DeterminationY Chromosome Detection
OBJECTIVE: Fetal cells from the maternal circulation (FCMBs) have the potential to replace cells from amniotic fluid or chorionic villi in a diagnosis of common chromosomal aneuploidies. Good markers for enrichment and identification are lacking. METHOD: Blood samples from 78 normal pregnancies were used for testing the marker-set CD105 and CD141 for fetal cell enrichment. Fetal cell candidates were subsequently stained by a cocktail of cytokeratin antibodies, and the gender of the fetal cells was explored by fluorescence in situ hybridization (FISH) of the X and Y chromosomes. RESULTS: Fetal cell candidates could be detected in 91% of the samples, and in 85% of the samples, it was possible to obtain X and Y chromosomal FISH results for gender determination. The concordance between gender determined by FISH on fetal cells in maternal blood and gender found at birth reached 100% if three or more fetal cells with FISH signals could be found in a sample. CONCLUSION: The marker set identifies fetal cells with specificity high enough to make cell-based noninvasive prenatal diagnosis realistic.
12
Marek Kirszenbaum, Philippe Moreau, Éliane Gluckman et al. · Proceedings of the National Academy of Sciences · 1994 · 230 citations · Full text
Detection of Apoptotic Fetal Cells in Plasma of Pregnant Women
Inge J. van Wijk, Anneke C de Hoon, Rishma Jurhawan et al. · Clinical Chemistry · 2000 · 97 citations · Full text
Pharmacy, Biochemistry, Obstetrics +10